ABBV : Analysis & Opinions

  1. Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

    March 25, 2014
    Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
  2. Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook

    December 3, 2013
    Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
  3. Pfizer Looking A Little Tired

    July 30, 2013
    Pfizer gets a boost from better margins, but the growth outlook is pretty feeble.
  4. Positive Data for Novartis' Candidate - Analyst Blog

    July 9, 2013
    Novartis recently announced encouraging top-line data from a phase III study, FIXTURE, on psoriasis candidate, secukinumab ...
  5. Priority Review for Roche Candidate - Analyst Blog

    July 5, 2013
    Roche's Biologics License Application (BLA) for oncology candidate obinutuzumab (GA101) was recently accepted by the FDA ...
  6. Abbott Progresses with Absorb in Japan - Analyst Blog

    June 14, 2013
    Abbott Labs (ABT) recently announced that it has initiated a randomized controlled study in Japan to evaluate Absorb, its ...
  7. New Data on UCB's Cimzia - Analyst Blog

    June 14, 2013
    UCB presented new data from the RAPID-PsA study and RAPID-axSpA study on Cimzia at the European League Against Rheumatism ...
  8. Label Expansion for Roche's RoActemra - Analyst Blog

    June 12, 2013
    Roche announced that it obtained European Medicines Agency (EMA) approval for the label expansion of its rheumatoid arthritis ...
  9. Warning: The Rebound May Be Over For Big Pharma

    June 10, 2013
    As investors were picking up the pieces after the dot-com implosion, they came across another troubled sector. A series ...
  10. Abbott Beats on EPS, Guides In-Line - Analyst Blog

    January 23, 2013
    Abbott Labs (ABT) reported fourth quarter 2012 earnings of $1.51 per share, a penny ahead of the Zacks Consensus Estimate ...
  11. Abbott Labs Spins Off AbbVie: Which Is The Better Buy?

    January 4, 2013
    January 2 was the first day of trading for the pharmaceutical spin-off.
  12. Abbott Spins Off Pharma Business - Analyst Blog

    January 3, 2013
    Abbott Laboratories (ABT) recently announced that the company has separated its research-based pharmaceuticals business by ...
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center